MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

被引:172
|
作者
Mielech, Anna M. [1 ]
Kilianski, Andy [1 ]
Baez-Santos, Yahira M. [2 ]
Mesecar, Andrew D. [2 ]
Baker, Susan C. [1 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA
[2] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
关键词
MERS-CoV; PLpro; DUB activity; Ubiquitin; deISGylating activity; ISG15; RESPIRATORY SYNDROME CORONAVIRUS; INNATE IMMUNE-RESPONSES; NONSTRUCTURAL PROTEIN-2; CLINICAL-FEATURES; VIRUS; DOMAIN; REPLICATION; ANTAGONISM; CELLS; ARTERIVIRUS;
D O I
10.1016/j.virol.2013.11.040
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronaviruses encode papain-like proteases (PLpro) that are often multifunctional enzymes with protease activity to process the viral replicase polyprotein and deubiquitinating (DUB)/deISGylating activity, which is hypothesized to modify the innate immune response to infection. Here, we investigate the predicted DUB activity of the PLpro domain of the recently described Middle East Respiratory Syndrome Coronavirus (MERS-CoV). We found that expression of MERS-CoV PLpro reduces the levels of ubiquitinated and ISGylated host cell proteins; consistent with multifunctional PLpro activity. Further, we compared the ability of MERS-CoV PLpro and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) PLpro to block innate immune signaling of proinflammatory cytokines. We show that expression of SARS-CoV and MERS-CoV PLpros blocks upregulation of cytokines CCL5, IFN-beta and CXCL10 in stimulated cells. Overall these results indicate that the PLpro domains of MERS-CoV and SARS-CoV have the potential to modify the innate immune response to viral infection and contribute to viral pathogenesis. (C) 2013 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [31] Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
    Klemm, Theresa
    Ebert, Gregor
    Calleja, Dale J.
    Allison, Cody C.
    Richardson, Lachlan W.
    Bernardini, Jonathan P.
    Lu, Bernadine G. C.
    Kuchel, Nathan W.
    Grohmann, Christoph
    Shibata, Yuri
    Gan, Zhong Yan
    Cooney, James P.
    Doerflinger, Marcel
    Au, Amanda E.
    Blackmore, Timothy R.
    van der Heden van Noort, Gerbrand J.
    Geurink, Paul P.
    Ovaa, Huib
    Newman, Janet
    Riboldi-Tunnicliffe, Alan
    Czabotar, Peter E.
    Mitchell, Jeffrey P.
    Feltham, Rebecca
    Lechtenberg, Bernhard C.
    Lowes, Kym N.
    Dewson, Grant
    Pellegrini, Marc
    Lessene, Guillaume
    Komander, David
    EMBO JOURNAL, 2020, 39 (18):
  • [32] Targeting SARS-CoV-2 papain-like protease in the postvaccine era
    Ton, Anh-Tien
    Pandey, Mohit
    Smith, Jason R.
    Ban, Fuqiang
    Fernandez, Michael
    Cherkasov, Artem
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (11) : 906 - 919
  • [33] Structural and biochemical characterization of SADS-CoV papain-like protease 2
    Wang, Lu
    Hu, Weihua
    Fan, Chengpeng
    PROTEIN SCIENCE, 2020, 29 (05) : 1228 - 1241
  • [34] Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo
    van Huizen, Mariska
    Bloeme-ter Horst, Jonna R.
    de Gruyter, Heidi L. M.
    Geurink, Paul P.
    van Noort, Gerbrand J. van der Heden
    Knaap, Robert C. M.
    Nelemans, Tessa
    Ogando, Natacha S.
    Leijs, Anouk A.
    Urakova, Nadya
    Mark, Brian L.
    Snijder, Eric J.
    Myeni, Sebenzile K.
    Kikkert, Marjolein
    PLOS PATHOGENS, 2024, 20 (03) : 1 - 31
  • [35] Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro
    Kiba, Yuka
    Tanikawa, Takashi
    Kitamura, Masashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (05) : 965 - 966
  • [36] Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
    Ma, Chunlong
    Wang, Jun
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (02) : 102 - 109
  • [37] SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition
    Ullrich, Sven
    Nitsche, Christoph
    CHEMBIOCHEM, 2022, 23 (19)
  • [38] Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
    Tan, Haozhou
    Hu, Yanmei
    Jadhav, Prakash
    Tan, Bin
    Wang, Jun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (11) : 7561 - 7580
  • [39] Myricetin inhibits transmissible gastroenteritis virus replication by targeting papain-like protease deubiquitinating enzyme activity
    Fan, Jiahao
    Xi, Pengyuan
    Liu, Huimao
    Song, Xu
    Zhao, Xinghong
    Zhou, Xun
    Zou, Yuanfeng
    Fu, Yuping
    Li, Lixia
    Jia, Renyong
    Yin, Zhongqiong
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [40] Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases
    Kandeel, Mahmoud
    Altaher, Abdallah
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (07) : 1086 - 1091